Table IV.
Sclerotic-type chronic GVHD | Systemic sclerosis | |
---|---|---|
Autoantibodies | Variable, nonspecific | Yes, associated with specific clinical subtypes |
Cardiac involvement | Rare | Yes, conduction system abnormalities |
Gastrointestinal dysmotility/strictures | Yes | Yes |
Pulmonary hypertension | No | Yes |
Pulmonary fibrosis | Yes* | Yes |
Renal disease | Rare, nephrotic syndrome | Yes, scleroderma renal crises (in diffuse subtype) |
Raynaud disease | Rare | Yes |
Sclerodactyly Skin manifestations | Rare | Yes |
Fibrosis | Dermis, subcutaneous tissue, and/or fascia | Dermis |
Natural history | Patchy involvement, variable course | Symmetric, acral to proximal progression |
Facial involvement | Rare, usually patchy involvement | Common, diffuse skin tightening (scleroderma facies) |
GVHD, Graft-versus-host disease.
In the setting of bronchiolitis obliterans.